TFF2 and neoplasm: Both wild-type and Tff2-null mice injected with Ad-Tff2 had fewer peripheral MDSCs in blood and spleen (Fig. 5b,c and Supplementary Fig. 9c), and developed significantly fewer tumours versus control (Fig. 5d-g).